The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 26, 2005
Filed:
Apr. 22, 2002
Joel Hedgpeth, San Francisco, CA (US);
Irina A. Afonina, Mill Creek, WA (US);
Igor V. Kutyavin, Bothell, WA (US);
Eugeny A. Lukhtanov, Bothell, WA (US);
Evgeniy S. Belousov, Mill Creek, WA (US);
Rich B. Meyer, Jr., Bothell, WA (US);
Joel Hedgpeth, San Francisco, CA (US);
Irina A. Afonina, Mill Creek, WA (US);
Igor V. Kutyavin, Bothell, WA (US);
Eugeny A. Lukhtanov, Bothell, WA (US);
Evgeniy S. Belousov, Mill Creek, WA (US);
Rich B. Meyer, Jr., Bothell, WA (US);
Epoch Biosciences, Inc., Bothell, WA (US);
Abstract
Conjugates between a minor groove binding molecule, such as the trimer of 1,2-dihydro-(3H)-pyrrolo[3,2-e]indole-7-carboxylate (CDPI), and an oligonucleotide form unusually stable hybrids with complementary target sequences, in which the tethered CDPIgroup resides in the minor groove of the duplex. These conjugates can be used as probes and primers. Due to their unusually high binding affinity, conjugates as short as 8-mers can be used as amplification primers with high specificity and efficiency. MGB conjugation also increases the discriminatory power of short oligonucleotides, providing enhanced detection of nucleotide sequence mismatches by short oligonucleotides. The MGB-conjugated probes and primers described herein facilitate various analytic and diagnostic procedures, such as amplification reactions, PCR, detection of single-nucleotide polymorphisms, gene hunting, differential display, fluorescence energy transfer, hydrolyzable probe assays and others; by allowing the use of shorter oligonucleotides, which have higher specificity and better discriminatory power.